Regulation of the alternative pathway on injured cells by factor H, FHL-1 and C-reactive protein

Publisher： Elsevier

ISSN： 0162-3109

Source： Immunopharmacology, Vol.49, Iss.1, 2000-08, pp. : 69-69

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Evaluation of the Significance of Circulating Insulin-like Growth Factor-1 and C-reactive Protein in Patients with Chronic Obstructive Pulmonary Disease

By Ye M Yu H Yu W Zhang G Xiao L Zheng X Wu J

The Journal of International Medical Research, Vol. 40, Iss. 3, 2012-05 ,pp. : 1025-1035

Field House Publishing

Access to resources Recommend Favorite

The biological functions of C-reactive protein

By Szalai A.J.

General Pharmacology, Vol. 39, Iss. 3, 2002-08 ,pp. : 105-107

Elsevier

Access to resources Recommend Favorite

QOL effects of C-reactive protein levels in diabetes

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 442, 2003-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Relating statin therapy to C-reactive protein levels

By Doggrell Sheila A

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 9, 2005-08 ,pp. : 1597-1600

Informa Healthcare

Access to resources Recommend Favorite

C-Reactive Protein and Hypertension: Is there A Causal Relationship?

Current Pharmaceutical Design, Vol. 13, Iss. 16, 2007-06 ,pp. : 1693-1698

Bentham Science Publishers

Access to resources Recommend Favorite